Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybridos in HSDD with Maladaptive Inhibition
NCT01743235Phase 2Completed
- Sponsor
- Emotional Brain
- Start
- Jul 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lybridos in hypoactive sexual desire disorder (HSDD), sponsored by Emotional Brain. Primary endpoint: Satisfactory Sexual Episodes at 20 weeks. Started Jul 2012; status: completed.
02
Drugs
Lybridos
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT01743235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743235.